Policy | October 27, 2021
PLI scheme has the potential to make India a pharma hub: Dr Mandaviya
FDI increased 98% year on year in 2020 and pharma exports grew by 18% in the last financial year
FDI increased 98% year on year in 2020 and pharma exports grew by 18% in the last financial year
Filing marks first protein-based vaccine submitted to MHRA for authorization
Support from DFC will help produce one billion vaccine doses by the end of 2022
It is the first company to launch Remogliflozin, Vildagliptin and Metformin combination
Key takeaways of recent quarter & conference call highlights
Key takeaways of recent quarter & conference call highlights
The company’s wide therapeutic portfolio helped to sustain growth despite changing market demand
It has exercised intellectual property options from IP Group regarding research results generated by the UK Cystic Fibrosis Gene Therapy Consortium, and from Oxford Biomedica regarding their lentiviral vector technology
The quarter also saw continued investment in new technologies and the successful implementation of several digitization and automation projects across operations
The new products include the COAG Line automated, semi-automated and POC systems manufactured by Diagon Hungary
Subscribe To Our Newsletter & Stay Updated
